Phibro Animal Health Corp
PAHC19.490
▲0.520
▲2.74%
- 最高位
- 19.610
- 最低位
- 19.050
- 開市價
- --
- 前收市價
- 18.970
- 成交量(千)
- 1.24
- 成交額(百萬)
- 0.20
- 買入
- --
- 賣出
- --
- 每手股數
- --
- 市值(百萬)
- 789.42
- 市盈率
- 13.440
- 息率
- 2.53%
- 差價
- --
- 52週高低
- 31.000 - 17.280
所有資料不保證絕對正確、完整、或實時，僅作為參考使用。投資涉及風險，過往業績並不代表將來表現，作任何投資決定或交易前，閣下應諮詢獨立專業意見。所有內容均不構成投資建議。
企業資料
- 公司名稱
- Phibro Animal Health Corp
- 證券代碼
- PAHC.US
- 所屬板塊
- Drug Manufacturers - Specialty & Generic
- 公司業務
- Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the US and other international countries.
- 發行量
- 40503608
- 公司總部
- 300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East
- 公司網址
- https://www.pahc.com
- 公司電郵
- investor.relations@pahc.com
- 公司電話
- +1 201 329-7300
暫無內容
關於
Phibro Animal Health Corp(PAHC.US)所屬的行業板塊為Drug Manufacturers - Specialty & Generic。
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the US and other international countries.
截至27/05 12:14:59，Phibro Animal Health Corp的股價升2.74，市值789.42百萬。Phibro Animal Health Corp的市盈率及息率分別為13.440及2.53%。
詳細公司背景可參考: https://www.pahc.com。